Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Neuropathic Pain Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neuropathic Pain Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neuropathic Pain Therapeutics Overall Market Size
2.1 Global Neuropathic Pain Therapeutics Market Size: 2021 VS 2028
2.2 Global Neuropathic Pain Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neuropathic Pain Therapeutics Players in Global Market
3.2 Top Global Neuropathic Pain Therapeutics Companies Ranked by Revenue
3.3 Global Neuropathic Pain Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Neuropathic Pain Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Neuropathic Pain Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neuropathic Pain Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Neuropathic Pain Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Neuropathic Pain Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Neuropathic Pain Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Anticonvulsants
4.1.3 Antidepressants
4.1.4 NSAIDs
4.1.5 Opioids
4.1.6 Steroids
4.1.7 Others
4.2 By Type - Global Neuropathic Pain Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Neuropathic Pain Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Neuropathic Pain Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Neuropathic Pain Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neuropathic Pain Therapeutics Market Size, 2021 & 2028
5.1.2 Diabetic Neuropathy
5.1.3 Chemotherapy-Induced Neuropathy Pain
5.1.4 Postherpetic Neuralgia
5.1.5 Spinal Cord Injury
5.1.6 Others
5.2 By Application - Global Neuropathic Pain Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Neuropathic Pain Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Neuropathic Pain Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Neuropathic Pain Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Neuropathic Pain Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Neuropathic Pain Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Neuropathic Pain Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Neuropathic Pain Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Neuropathic Pain Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Neuropathic Pain Therapeutics Revenue, 2017-2028
6.3.2 US Neuropathic Pain Therapeutics Market Size, 2017-2028
6.3.3 Canada Neuropathic Pain Therapeutics Market Size, 2017-2028
6.3.4 Mexico Neuropathic Pain Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Neuropathic Pain Therapeutics Revenue, 2017-2028
6.4.2 Germany Neuropathic Pain Therapeutics Market Size, 2017-2028
6.4.3 France Neuropathic Pain Therapeutics Market Size, 2017-2028
6.4.4 U.K. Neuropathic Pain Therapeutics Market Size, 2017-2028
6.4.5 Italy Neuropathic Pain Therapeutics Market Size, 2017-2028
6.4.6 Russia Neuropathic Pain Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Neuropathic Pain Therapeutics Market Size, 2017-2028
6.4.8 Benelux Neuropathic Pain Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Neuropathic Pain Therapeutics Revenue, 2017-2028
6.5.2 China Neuropathic Pain Therapeutics Market Size, 2017-2028
6.5.3 Japan Neuropathic Pain Therapeutics Market Size, 2017-2028
6.5.4 South Korea Neuropathic Pain Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Neuropathic Pain Therapeutics Market Size, 2017-2028
6.5.6 India Neuropathic Pain Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Neuropathic Pain Therapeutics Revenue, 2017-2028
6.6.2 Brazil Neuropathic Pain Therapeutics Market Size, 2017-2028
6.6.3 Argentina Neuropathic Pain Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Neuropathic Pain Therapeutics Revenue, 2017-2028
6.7.2 Turkey Neuropathic Pain Therapeutics Market Size, 2017-2028
6.7.3 Israel Neuropathic Pain Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Neuropathic Pain Therapeutics Market Size, 2017-2028
6.7.5 UAE Neuropathic Pain Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Neuropathic Pain Therapeutics Major Product Offerings
7.1.4 Pfizer Neuropathic Pain Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Pfizer Key News
7.2 Novartis AG
7.2.1 Novartis AG Corporate Summary
7.2.2 Novartis AG Business Overview
7.2.3 Novartis AG Neuropathic Pain Therapeutics Major Product Offerings
7.2.4 Novartis AG Neuropathic Pain Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Novartis AG Key News
7.3 AstraZeneca
7.3.1 AstraZeneca Corporate Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Neuropathic Pain Therapeutics Major Product Offerings
7.3.4 AstraZeneca Neuropathic Pain Therapeutics Revenue in Global Market (2017-2022)
7.3.5 AstraZeneca Key News
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Corporate Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Neuropathic Pain Therapeutics Major Product Offerings
7.4.4 GlaxoSmithKline Neuropathic Pain Therapeutics Revenue in Global Market (2017-2022)
7.4.5 GlaxoSmithKline Key News
7.5 Eli Lilly and Company
7.5.1 Eli Lilly and Company Corporate Summary
7.5.2 Eli Lilly and Company Business Overview
7.5.3 Eli Lilly and Company Neuropathic Pain Therapeutics Major Product Offerings
7.5.4 Eli Lilly and Company Neuropathic Pain Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Eli Lilly and Company Key News
7.6 Mallinckrodt Pharmaceuticals
7.6.1 Mallinckrodt Pharmaceuticals Corporate Summary
7.6.2 Mallinckrodt Pharmaceuticals Business Overview
7.6.3 Mallinckrodt Pharmaceuticals Neuropathic Pain Therapeutics Major Product Offerings
7.6.4 Mallinckrodt Pharmaceuticals Neuropathic Pain Therapeutics Revenue in Global Market (2017-2022)
7.6.5 Mallinckrodt Pharmaceuticals Key News
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Corporate Summary
7.7.2 Johnson & Johnson Business Overview
7.7.3 Johnson & Johnson Neuropathic Pain Therapeutics Major Product Offerings
7.7.4 Johnson & Johnson Neuropathic Pain Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Johnson & Johnson Key News
7.8 Abbott
7.8.1 Abbott Corporate Summary
7.8.2 Abbott Business Overview
7.8.3 Abbott Neuropathic Pain Therapeutics Major Product Offerings
7.8.4 Abbott Neuropathic Pain Therapeutics Revenue in Global Market (2017-2022)
7.8.5 Abbott Key News
7.9 Endo Pharmaceuticals, Inc.
7.9.1 Endo Pharmaceuticals, Inc. Corporate Summary
7.9.2 Endo Pharmaceuticals, Inc. Business Overview
7.9.3 Endo Pharmaceuticals, Inc. Neuropathic Pain Therapeutics Major Product Offerings
7.9.4 Endo Pharmaceuticals, Inc. Neuropathic Pain Therapeutics Revenue in Global Market (2017-2022)
7.9.5 Endo Pharmaceuticals, Inc. Key News
7.10 Teva Pharmaceutical Industries Limited
7.10.1 Teva Pharmaceutical Industries Limited Corporate Summary
7.10.2 Teva Pharmaceutical Industries Limited Business Overview
7.10.3 Teva Pharmaceutical Industries Limited Neuropathic Pain Therapeutics Major Product Offerings
7.10.4 Teva Pharmaceutical Industries Limited Neuropathic Pain Therapeutics Revenue in Global Market (2017-2022)
7.10.5 Teva Pharmaceutical Industries Limited Key News
7.11 Merck & Co
7.11.1 Merck & Co Corporate Summary
7.11.2 Merck & Co Business Overview
7.11.3 Merck & Co Neuropathic Pain Therapeutics Major Product Offerings
7.11.4 Merck & Co Neuropathic Pain Therapeutics Revenue in Global Market (2017-2022)
7.11.5 Merck & Co Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer